Home > Insider Trading > Filing (0001415889-24-020035)

Filing Details

Accession Number:: 0001415889-24-020035
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-07-24 16:15:09
Reporting Period:: 2024-07-22

Accepted Time:: 2024-07-24 16:15:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1817241	Artiva Biotherapeutics Inc.	ARTV	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1598549	J. Andrew Schwab	C/O 5Am Venture Management, Llc 4 Embarcadero Center, Suite 3110 San Francisco CA 94111	No	No	Yes	No
1664281	Kush Parmar	C/O 5Am Venture Management, Llc 4 Embarcadero Center, Suite 3110 San Francisco CA 94111	No	No	Yes	No
1753037	5Am Ventures Vi, L.p.	4 Embarcadero Center, Suite 3110 San Francisco CA 94111	No	No	Yes	No
1829051	5Am Partners Vi, Llc	4 Embarcadero Center, Suite 3110 San Francisco CA 94111	No	No	No	No
1844401	5Am Opportunities Ii, L.p.	4 Embarcadero Center, Suite 3110 San Francisco CA 94111	No	No	Yes	No
1873515	5Am Opportunities Ii (Gp), Llc	4 Embarcadero Center, Suite 3110 San Francisco CA 94111	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-07-22	1,058,284	$0.00	1,058,284	No	4	C	Indirect	By 5AM Ventures VI, L.P.
Common Stock	Acquisiton	2024-07-22	112,966	$10.20	1,171,250	No	4	J	Indirect	By 5AM Ventures VI, L.P.
Common Stock	Acquisiton	2024-07-22	348,721	$10.20	348,721	No	4	J	Indirect	By 5AM Opportunities II, L.P.
Common Stock	Acquisiton	2024-07-22	833,333	$12.00	1,182,054	No	4	P	Indirect	By 5AM Opportunities II, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By 5AM Ventures VI, L.P.
No	4	J	Indirect	By 5AM Ventures VI, L.P.
No	4	J	Indirect	By 5AM Opportunities II, L.P.
No	4	P	Indirect	By 5AM Opportunities II, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2024-07-22	843,592	$0.00	843,592	$0.00
Common Stock	Series B Preferred Stock	Disposition	2024-07-22	214,692	$0.00	214,692	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a one-for-one basis without payment of further consideration. Upon the closing of the Issuer's initial public offering (the "IPO"), the Preferred Stock wasconverted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Preferred Stock had no expiration date.
The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI, Dr. Parmar, and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.
Represents the conversion of outstanding simple agreement for future equity in the amount of $1,152,253.93 into shares of the Issuer's common stock upon closing of the Issuer's IPO at a 15% discount to the IPO price.
Represents the conversion of outstanding simple agreement for future equity in the amount of $3,556,957.78 into shares of the Issuer's common stock upon closing of the Issuer's IPO at a 15% discount to the IPO price.
Shares are held by 5AM Opportunities II, L.P. ("Opportunities II"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the general partner of Opportunities II and may be deemed to have sole investment and voting power over the shares held by Opportunities II. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Opportunities II GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities II. Each of Opportunities II GP, Dr. Parmar and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein.